BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11734894)

  • 1. Classification and phylogenetic analysis of the cAMP-dependent protein kinase regulatory subunit family.
    Canaves JM; Taylor SS
    J Mol Evol; 2002 Jan; 54(1):17-29. PubMed ID: 11734894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
    Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK2-mediated phosphorylation of a type II regulatory subunit of cAMP-dependent protein kinase from the mollusk Mytilus galloprovincialis.
    Bardales JR; Hellman U; Villamarín JA
    Arch Biochem Biophys; 2007 May; 461(1):130-7. PubMed ID: 17379180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational differences among solution structures of the type Ialpha, IIalpha and IIbeta protein kinase A regulatory subunit homodimers: role of the linker regions.
    Vigil D; Blumenthal DK; Heller WT; Brown S; Canaves JM; Taylor SS; Trewhella J
    J Mol Biol; 2004 Apr; 337(5):1183-94. PubMed ID: 15046986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
    Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
    J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
    Yu S; Mei FC; Lee JC; Cheng X
    Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearrangements in a hydrophobic core region mediate cAMP action in the regulatory subunit of PKA.
    Hahnefeld C; Moll D; Goette M; Herberg FW
    Biol Chem; 2005 Jul; 386(7):623-31. PubMed ID: 16207083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of an electrostatic relay switch critical for the cAMP-dependent activation of protein kinase A as revealed by the D170A mutant of RIalpha.
    Abu-Abed M; Das R; Wang L; Melacini G
    Proteins; 2007 Oct; 69(1):112-24. PubMed ID: 17596845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of AKAP specificity for PKA regulatory subunits.
    Gold MG; Lygren B; Dokurno P; Hoshi N; McConnachie G; Taskén K; Carlson CR; Scott JD; Barford D
    Mol Cell; 2006 Nov; 24(3):383-95. PubMed ID: 17081989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoform specific differences in binding of a dual-specificity A-kinase anchoring protein to type I and type II regulatory subunits of PKA.
    Burns LL; Canaves JM; Pennypacker JK; Blumenthal DK; Taylor SS
    Biochemistry; 2003 May; 42(19):5754-63. PubMed ID: 12741833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic binding of PKA regulatory subunit RI alpha.
    Gullingsrud J; Kim C; Taylor SS; McCammon JA
    Structure; 2006 Jan; 14(1):141-9. PubMed ID: 16407073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA.
    Kim C; Xuong NH; Taylor SS
    Science; 2005 Feb; 307(5710):690-6. PubMed ID: 15692043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous tryptophan residues of cAPK regulatory subunit type IIbeta reveal local variations in environments and dynamics.
    Zawadzki KM; Pan CP; Barkley MD; Johnson D; Taylor SS
    Proteins; 2003 Jun; 51(4):552-61. PubMed ID: 12784214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
    Kim C; Cheng CY; Saldanha SA; Taylor SS
    Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution scattering reveals large differences in the global structures of type II protein kinase A isoforms.
    Vigil D; Blumenthal DK; Taylor SS; Trewhella J
    J Mol Biol; 2006 Mar; 357(3):880-9. PubMed ID: 16460759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV; Cho-Chung YS
    Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of substrate on type I and type II PKA holoenzyme dissociation.
    Vigil D; Blumenthal DK; Brown S; Taylor SS; Trewhella J
    Biochemistry; 2004 May; 43(19):5629-36. PubMed ID: 15134437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
    Prinz A; Diskar M; Erlbruch A; Herberg FW
    Cell Signal; 2006 Oct; 18(10):1616-25. PubMed ID: 16524697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric network of cAMP-dependent protein kinase revealed by mutation of Tyr204 in the P+1 loop.
    Yang J; Garrod SM; Deal MS; Anand GS; Woods VL; Taylor S
    J Mol Biol; 2005 Feb; 346(1):191-201. PubMed ID: 15663937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.